Tools
Tools
Yates, M. 
ORCID: https://orcid.org/0000-0003-3977-8920, Saha, P., Aldus, C., Brown, J. and Macgregor, A. ORCID: https://orcid.org/0000-0003-2163-2325
(2024)
POS0411 Characteristics at diagnosis associated to glucocorticoid use at 2 years for those with polymyalgia rheumatica - A national study of England.
In: UNSPECIFIED.
Abstract
Current guidelines recommend glucocorticoids (GCs) for the treatment of Polymyalgia Rheumatica (PMR) for 1 to 2 years. Surveys and administrative datasets from many European countries and the USA show that approximately 50% of patients are on GCs for at least 2 years. A previous study looking at individuals with PMR and GC dependence, found the neutrophil-lymphocyte ratio (NLR) at diagnosis to be associated with GC dependency.
Actions (login required)
 |
View Item |